Resmed Inc. buy UBS Group AG
Start price
20.09.25
/
50%
€234.30
Target price
20.09.26
-
Performance (%)
-0.73%
Price
22.09.25
€232.60
Summary
This prediction is currently active. Since the start of the prediction for Resmed Inc. the price has only changed by -0.73%. This prediction currently runs until 20.09.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Resmed Inc. | -0.73% |
| iShares Core DAX® | -0.560% |
| iShares Nasdaq 100 | 1.622% |
| iShares Nikkei 225® | 1.807% |
| iShares S&P 500 | 0.859% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for RMD provided by MarketBeat